Enhancement of post-ischemic myocardial function by chronic 17β-estradiol treatment: Role of alterations in glucose metabolism

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 8, 1999, Pages 1539-1549

  Fraser, Heather ^a   Davidge, Sandra T ^a   Clanachan, Alexander S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Estrogen; Glucose metabolism; Glycogen; Left ventricular function; Myocardial ischemia; Myocardial reperfusion

Indexed keywords

ESTRADIOL; GLUCOSE; GLYCOGEN SYNTHASE; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN THERAPY; FEMALE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; GLYCOGEN ANALYSIS; GLYCOGEN METABOLISM; GLYCOLYSIS; HEART FUNCTION; HEART PERFUSION; HEART PROTECTION; ISCHEMIA; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPERFUSION;

EID: 0033179253     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0986     Document Type: Article

References (40)

1. Carrington LJ, Bailey CJ, 1985. Effects of natural and synthetic estrogens and progestins on glycogen deposition in female mice. Horm Res 21: 199-203.
2. Collins-Nakai RL, Noseworthy D, Lopaschuk GD, 1994. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. Am J Physiol 267: H1862-H1871.
3. Comte B, Vincent G, Bouchard B, Jette M, Cordeau S, Rosiers CD, 1997. A 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat hearts. J Biol Chem 272: 26125-26131.
4. Constantin-Teodosiu D, Cederblad G, Hultman E, 1991. A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Analyt Biochem 198: 347-351.
5. Dahm CH Jr, Jellinek M, Minagawa J, Rao PS, 1978. Effects of estradiol-17β on some gluconeogenic enzymes in rat liver. Biol Reprod 18: 734-735.
6. Delyani JA, Murohara T, Nossuli TO, Lefer AM, 1996. Protection from myocardial reperfusion injury by acute administration of 17β-estradiol. J Mol Cell Cardiol 28: 1001-1008.
7. Dennis SC, Gevers W, Opie LH, 1991. Protons in ischemia: Where do they come from; where do they go to? J Mol Cell Cardiol 23: 1077-1086.
8. Denton RM, McCormack JG, Rutter GA, Burnett P, Edgell NJ, Moule SK, Diggle TA, 1996. The hormonal regulation of pyruvate dehydrogenase complex. Adv Enzyme Regul 36: 183-198.
9. Dobson JG JR, Fenton RA, 1993. Adenosine inhibition of beta-adrenergic induced responses in aged hearts. Am J Physiol 265: H494-H503.
10. Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS, 1993. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation 87: 900-908.
11. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS, 1995. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 269: H1767-H1775.
12. 1 receptor stimulation during reperfusion following ischaemia. Br J Pharmacol 118: 355-363.
13. Fraser H, Lopaschuk GD, Clanachan AS, 1998. Assessment of glycogen turnover in aerobic, ischemic and reperfused working rat hearts. Am J Physiol 275: H1533-H1541.
14. Furman RH, 1968. Are gonadal hormones (estrogens and androgens) of significance in the development of ischemic heart disease. Ann NY Acad Sci 149: 822-833.
15. Ginsburg ES, Gao X, Shea BF, Barbieri RL, 1998. Halflife of estradiol in postmenopausal women. Gynecol Obstet Invest 45: 45-48.
16. Gradinac S, Coleman GM, Taegtmeyer H, Sweeney MS, Frazier OH, 1989. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg 48: 484-489.
17. GraDy D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR, 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037.
18. Hale SL, Birnbaum Y, Kloner RA, 1996. β-estradiol, but not α-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J 132: 258- 262.
19. Henning SL, Wambolt RB, Schonekess BO, Lopaschuk GD, Allard MF, 1996. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation 93: 1549-1555.
20. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613.
21. Kendrick ZV, Steffen CA, Rumsey WL, Goldberg DI, 1987. Effect of estradiol on tissue glycogen metabolism in exercised oophorectomized rats. J Appl Physiol 63: 492-496.
22. King LM, Opie LH, 1998. Glucose and glycogen utilisation in myocardial ischemia - Changes in metabolism and consequences for the myocyte. Mol Cell Biochem 180: 3-26.
23. Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, Lee SJ, Virmani R, 1997. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol 29: 2403-2414.
24. Kostanyan A, Nazaryan K, 1992. Rat brain glycolysis regulation by estradiol-17β. Biochim Biophys Acta 1133: 301-306.
25. Liu B, Clanachan AS, Schulz R, Lopaschuk GD, 1996. Cardiac efficiency is improved after ischemia by altering both the course and fate of protons. Circ Res 79: 940-948.
26. Lopaschuk GD, 1997. Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. Am J Cardiol 80: 11A-16A.
27. Lopaschuk GD, Stanley WC, 1997. Glucose metabolism in the ischemic heart. Circulation 95: 313-315.
28. Lopaschuk GD, Wambolt RB, Barr RL, 1993. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 264: 135-144.
29. Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, Finegan BA, 1994. Plasma fatty acid levels in infants and adults after myocardial ischemia. Am Heart J 128: 61-67.
30. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD, 1996. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93: 135-142.
31. McVeigh JJ, Lopaschuk GD, 1990. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 259: H1079-H1085.
32. Passonneau JV, Rottenberg DA, 1973. An assessment of methods for measurement of glycogen synthetase activity including a new direct one-step assay. Anal Biochem 51: 528-541.
33. Randle PJ, Hales CN, Garland PB, Newsholme EA, 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
34. Rooney TP, Kendrick ZV, Carlson J, Ellis GS, Matakevich B, Lorusso SM, McCall JA, 1993. Effect of estradiol on the temporal pattern of exercise-induced tissue glycogen depletion in male rats. J Appl Physiol 75: 1502-1506.
35. Smith DE, 1967. Location of the estrogen effect on uterine glucose metabolism. Proc Soc Exp Biol Med 124: 746-749.
36. Stampfer MJ, Colditz GA, 1991. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prevent Med 20: 47-63.
37. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG, 1997. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33: 243-257.
38. Stevenson JC, Crook D, Godsland IF, 1993. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 98: 83-90.
39. Williams JK, Adams MR, Klopfenstein HS, 1990. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81: 1680-1687.
40. Wisneski JA, Stanley WC, Neese RA, Gertz EW, 1990. Effects of acute hyperglycemia on myocardial glycolytic activity in humans. J Clin Invest 85: 1648-1656.